The International Cannabinoid Research Society (the oldest scientific society dedicated to the research in the cannabis plant) has announced that the International Symposium on the Cannabinoids in 2021 will take place at the International Convention Center (ICC) in Jerusalem, in cooperation with the Jerusalem Conventions Visitors Bureau (JCVB), which operates under the Jerusalem Development Authority […]

by

Entering a marijuana dispensary nowadays can be a little intimidating, especially if you’re not well acquainted with the vast selection of different products available. Medical and recreational marijuana is on the rise, and the sheer number of products can make the most seasoned of cannabis users feel a little lost. Here is a brief overview […]

by

DEVON, Pa., Aug. 14, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal pharmaceutically-produced cannabinoid treatments, today reported top line results from its Phase 2 STOP (Synthetic Transdermal Cannabidiol for Treatment of Knee Pain due to Osteoarthritis) clinical trial evaluating ZYN002 (cannabidiol [CBD] gel). […]

by

The National Institutes of Health (NIH) is funding the first-ever, long-term study to research the impacts of medical marijuana on opioid use. The NIH has awarded a five-year $3.8 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study whether medical marijuana reduces opioid use among adults with chronic […]

by

Cannabis oil and topicals have been known to produce impressive results with skin conditions like eczema, psoriasis and different kinds of abrasions. A study conducted in 2010 tested a facial lotion that contained cannabinoids on people with postherpetic neuralgia, a pain condition similar to shingles, and the results were very surprising, demonstrating that the lotion […]

by

The National Institutes of Health (NIH) is funding the first-ever, long-term study to research the impacts of medical marijuana on opioid use. The NIH has awarded a five-year $3.8 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study whether medical marijuana reduces opioid use among adults with chronic […]

by